Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Obstructive sleep apnea (OSA) is a common sleep disorder ... and Critical Care Medicine offers hope for improving treatment. Researchers, including experts from the University of Missouri School ...

Low-level laser therapy is a non-invasive treatment for TMJ symptoms that uses light to stimulate cellular activity, and it's ...

An estimated 38,000 people die each year from heart disease complicated by sleep apnea. This article discusses how sleep apnea and anxiety are connected, including symptoms, treatment, and how to talk ...

The Solea Sleep laser therapy targets the soft palate ... While Solea Sleep does not treat obstructive sleep apnea (OSA), it can significantly improve the quality of life for those experiencing ...

There may even be thoughts of hurting oneself or others. When any of these symptoms occur, treating sleep apnea may help, but some people may additionally require the use of antidepressant medication ...

Sleep apnea involves repeated breathing interruptions during sleep, while loud snoring is steady and doesn’t typically affect breathing. A doctor can help confirm the difference. Sleep apnea is ...

"Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea," Seymour wrote. "This is a major step forward for patients with obstructive sleep apnea." ...

If you have high blood pressure that seems resistant to treatment, sleep apnea might be an underlying cause. If you recognize multiple signs from this list, it’s crucial to consult a healthcare ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...